> Ministries and Agencies > Agencies > Agency Details
Agency Details
(as on: Monday, November 23, 2009)
Ministry: HEALTH AND LONG-TERM CARE
Agency: COMMITTEE TO EVALUATE DRUGS
Agency URL: www.health.gov.on.ca/english/providers/program/drugs/how_drugs_approv/funding_ced.html
Address: c/o Drug Programs Branch 3rd Floor 5700 Yonge Street North York M2M 4K5 Ont.
Tel.: (416) 327-8109; 1(866)532-3161
Fax: (416) 327-8123
Background: MINISTRY OF HEALTH AND LONG-TERM CARE ACT, RSO 1990, C.M. 26, S.9; OC 2217/68; 415/71; 3478/72; 1798/82; 821/85; 137/87; 978/88; 1035/90; 754/93; 1284/94; 2731/94; 691/97; 2069/98; 2465/98; 1250/99; 1873/2006
Period: 23-MAY-1968 - N/A
Type: ADA
Prerogative: Permissive Legislation; Minister's OIC
Function: The Committee to Evaluate Drugs (CED) was established in 1968 to provide independent and specialised advice to the Ministry, including the executive officer for the Ontario public drug program, on drug related issues. The CED performs an advisory role for the Ministry on the operations of programs designed to assist the people of Ontario to obtain prescribed pharmaceutical products of quality at reasonable cost. Its key functions are to establish, maintain, and apply criteria to evaluate the quality and therapeutic value and cost of drug products and to recommend to the Minister, including the executive officer, those products which should be considered for publicly funded drug programs, and the conditions under which such products should be funded. The CED also recommends to the executive officer which drug products should be designated as interchangeable products or listed drug products for the purposes of the Drug Interchangeability and Dispensing Fee Act, and the Ontario Drug Benefit Act, and to monitor and evaluate, on a continuous basis, the list of drugs available in the light of drug use patterns, experience and current scientific knowledge. The CED also makes recommendations, when requested, to contribute and support Ministry efforts on education about publicly funded drugs and related issues. It reviews and assesses information related to drugs and pharmaceutical products prepared for the Committee and for the Minister by selected consultants. In addition, CED acts as liaison between the Minister or executive officer and professional, educational and other groups. It provides advice on relevant drug, pharmaceutical, policy, and therapeutic questions and issues solicited or requested by the Ministry.
Membership: The Lieutenant Governor in Council appoints not more than sixteen members plus the chair of which two members are lay persons. The Director of the Drug Programs Branch is designated as the Executive Secretary and the Associate Director of the Drug Programs Branch is designated as the Senior Consultant.
Term: Members serve for a term of three years, which may be renewed at the discretion of the Minister.
Meetings: The committee meets at least once a month to carry out its mandate with respect to drug product reviews, formulary review, ODB cost saving initiatives, and individual requests under Section 8(1) of the Ontario Drug Benefit Act, etc. A number of subcommittees have been established to assist in the review of drug product submissions, and other matters relevant to the mandate of the DQTC. These meet four to six times a year, as required.
Requirements: The member is not employed by any pharmaceutical or related companies; is able and willing to comply with Conflict of Interest and Confidentiality requirements of the Government of Ontario; has a professional degree from a recognized institution in at least one of the following disciplines: medicine, pharmacy, pharmacology or health economics; should be in active practice and or research in either the community, hospital or academic setting.
Agency: COMMITTEE TO EVALUATE DRUGS
Agency URL: www.health.gov.on.ca/english/providers/program/drugs/how_drugs_approv/funding_ced.html
Address: c/o Drug Programs Branch 3rd Floor 5700 Yonge Street North York M2M 4K5 Ont.
Tel.: (416) 327-8109; 1(866)532-3161
Fax: (416) 327-8123
Background: MINISTRY OF HEALTH AND LONG-TERM CARE ACT, RSO 1990, C.M. 26, S.9; OC 2217/68; 415/71; 3478/72; 1798/82; 821/85; 137/87; 978/88; 1035/90; 754/93; 1284/94; 2731/94; 691/97; 2069/98; 2465/98; 1250/99; 1873/2006
Period: 23-MAY-1968 - N/A
Type: ADA
Prerogative: Permissive Legislation; Minister's OIC
Function: The Committee to Evaluate Drugs (CED) was established in 1968 to provide independent and specialised advice to the Ministry, including the executive officer for the Ontario public drug program, on drug related issues. The CED performs an advisory role for the Ministry on the operations of programs designed to assist the people of Ontario to obtain prescribed pharmaceutical products of quality at reasonable cost. Its key functions are to establish, maintain, and apply criteria to evaluate the quality and therapeutic value and cost of drug products and to recommend to the Minister, including the executive officer, those products which should be considered for publicly funded drug programs, and the conditions under which such products should be funded. The CED also recommends to the executive officer which drug products should be designated as interchangeable products or listed drug products for the purposes of the Drug Interchangeability and Dispensing Fee Act, and the Ontario Drug Benefit Act, and to monitor and evaluate, on a continuous basis, the list of drugs available in the light of drug use patterns, experience and current scientific knowledge. The CED also makes recommendations, when requested, to contribute and support Ministry efforts on education about publicly funded drugs and related issues. It reviews and assesses information related to drugs and pharmaceutical products prepared for the Committee and for the Minister by selected consultants. In addition, CED acts as liaison between the Minister or executive officer and professional, educational and other groups. It provides advice on relevant drug, pharmaceutical, policy, and therapeutic questions and issues solicited or requested by the Ministry.
Membership: The Lieutenant Governor in Council appoints not more than sixteen members plus the chair of which two members are lay persons. The Director of the Drug Programs Branch is designated as the Executive Secretary and the Associate Director of the Drug Programs Branch is designated as the Senior Consultant.
Term: Members serve for a term of three years, which may be renewed at the discretion of the Minister.
Meetings: The committee meets at least once a month to carry out its mandate with respect to drug product reviews, formulary review, ODB cost saving initiatives, and individual requests under Section 8(1) of the Ontario Drug Benefit Act, etc. A number of subcommittees have been established to assist in the review of drug product submissions, and other matters relevant to the mandate of the DQTC. These meet four to six times a year, as required.
Requirements: The member is not employed by any pharmaceutical or related companies; is able and willing to comply with Conflict of Interest and Confidentiality requirements of the Government of Ontario; has a professional degree from a recognized institution in at least one of the following disciplines: medicine, pharmacy, pharmacology or health economics; should be in active practice and or research in either the community, hospital or academic setting.
| No. | POSITION | MEMBER NAME | TENURE | REMUNERATION | LOCATION |
|---|---|---|---|---|---|
| 1. | CHAIR (PART-TIME) | EVANS, GERALD A. | 06-FEB-2002 - 05-FEB-2011 | RETAINER | KINGSTON |
| 2. | MEMBER (PART-TIME) | JUURLINK, DAVID NELSON | 07-APR-2004 - 03-APR-2010 | $1000 PER DIEM | TORONTO |
| 3. | MEMBER (PART-TIME) | MARTIN, JANET | 07-APR-2004 - 15-APR-2011 | $1000 PER DIEM | LONDON |
| 4. | MEMBER (PART-TIME) | WINQUIST, ERIC WILLIAM | 07-APR-2004 - 22-APR-2011 | $1000 PER DIEM | LONDON |
| 5. | MEMBER (PART-TIME) | WU, HENRY | 01-JUN-2005 - 22-APR-2011 | $1000 PER DIEM | SCARBOROUGH |
| 6. | MEMBER (PART-TIME) | DAVEY, HARLON | 20-JUN-2007 - 19-JUN-2011 | $355 PER DIEM | MISSISSAUGA |
| 7. | MEMBER (PART-TIME) | WALKER, SCOTT ERNEST | 02-APR-2009 - 01-APR-2012 | $1000 PER DIEM | TORONTO |
| 8. | MEMBER (PART-TIME) | HOLBROOK, ANNE MARIE | 24-APR-1997 - 28-APR-2012 | $1000 PER DIEM | ANCASTER |
| 9. | MEMBER (PART-TIME) | GRILL, ALLAN | 30-JUN-2006 - 29-JUN-2012 | $1000 PER DIEM | TORONTO |
| 10. | MEMBER (PART-TIME) | COYLE, DOUGLAS (DOUG) | 17-JUL-2006 - 16-JUL-2012 | $1000 PER DIEM | OTTAWA |
This site is maintained by the Government of
Ontario
Privacy |
Important
Notices
©
Queen's Printer for Ontario, 2009
Last Modified: Tuesday, August 12, 2008